Cardiology Pharmaceuticals
July 17, 2025
It’s Official – Finerenone is Approved for HF July 17, 2025
One of the hardest-to-treat cardiac conditions just got a little more hopeful as the FDA approved Bayer’s KERENDIA (finerenone) for treating heart failure patients with left ventricular ejection fraction ≥40%, marking the first new pharmaceutical option for HF in years. While not originally intended for HF, KERENDIA’s approval stems from the 6k patient Phase III […]
Cardiovascular Disease
July 14, 2025
Good News and Bad News – CV Deaths Are Changing July 14, 2025
Good news – overall heart disease deaths in the U.S. have declined significantly since 1970. The bad news? According to a recent AHA study, several complex heart conditions are becoming increasingly responsible for cardiovascular deaths. Searching for trends in CV mortality, Stanford researchers analyzed over 50 years of CDC data, revealing dramatic changes in cardiac […]
Cardiology
July 10, 2025
Top 6 Cardiology Trends from 2025’s First Half July 10, 2025
The first half of 2025 is now over, and the world of cardiology keeps expanding. As we do every year, we’ve compiled a list of the top six stories of H1 – one for each month – to recap the big changes and innovations happening in cardiology. AI-ECG’s Hot Start and Fast Expansion 2025 kicked […]
